AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin
about
AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AM966, an Antagonist of Lysoph ...... Phosphorylation of VE-Cadherin
@en
AM966, an Antagonist of Lysoph ...... hosphorylation of VE-Cadherin.
@nl
type
label
AM966, an Antagonist of Lysoph ...... Phosphorylation of VE-Cadherin
@en
AM966, an Antagonist of Lysoph ...... hosphorylation of VE-Cadherin.
@nl
prefLabel
AM966, an Antagonist of Lysoph ...... Phosphorylation of VE-Cadherin
@en
AM966, an Antagonist of Lysoph ...... hosphorylation of VE-Cadherin.
@nl
P2860
P50
P356
P1476
AM966, an Antagonist of Lysoph ...... Phosphorylation of VE-Cadherin
@en
P2093
Junting Cai
Tomeka Suber
P2860
P304
P356
10.1155/2017/6893560
P577
2017-02-27T00:00:00Z